C3.ai, Inc. — FY2022 Form 10-K Summary
Reporting period: Fiscal year ended April 30, 2022, compared primarily with fiscal 2021. This is an annual report, not a standalone 2021 fourth-quarter filing; the supplied filing does not provide a clear standalone Q4 financial summary.
Business context
C3.ai sells enterprise AI software, principally subscriptions to its application platform and industry-specific applications, with additional professional services revenue. Its customers include large corporations and government entities, and it relies on direct sales and partners including Baker Hughes, AWS, Microsoft, Google Cloud, FIS and Raytheon.
Financial and operating results
| Metric | FY2022 | FY2021 | Change |
|---|---|---|---|
| Total revenue | $252.8 million | $183.2 million | +38% |
| Subscription revenue | $206.9 million | $157.4 million | +31% |
| Professional services revenue | $45.8 million | $25.9 million | +77% |
| Gross profit / margin | $189.0 million / 75% | $138.7 million / 76% | Margin down 1 percentage point |
| Operating expenses | $385.2 million | $199.0 million | +94% |
| Operating loss | $(196.1) million | $(60.3) million | Loss widened |
| Net loss | $(192.1) million | $(55.7) million | Loss widened |
| Operating cash flow | $(86.5) million | $(37.6) million | Cash use increased |
| Free cash flow | $(90.8) million | $(39.2) million | Cash use increased |
Subscription gross margin was 78% versus 80%; professional services gross margin improved to 61% from 49%. Sales and marketing expense rose 79% to $173.6 million and research and development expense rose 119% to $150.5 million. FY2022 stock-based compensation was $113.4 million, versus $21.7 million in FY2021.
At April 30, 2022, cash and cash equivalents were $339.5 million and investments were $652.7 million, totaling $992.2 million. Current assets were $1.06 billion and current liabilities $150.2 million. Total liabilities were $181.4 million; the filing reports operating lease liabilities of $30.5 million and no outstanding borrowing balance. The company reported an accumulated deficit of $541.4 million.
Remaining performance obligations (RPO) were $477.4 million, up from $293.8 million; $169.7 million was expected to be recognized over the next 12 months. RPO includes deferred revenue and non-cancellable contracted amounts, but excludes certain usage-based revenue and cancellable backlog.
Material changes and unusual items
- Revenue growth was supported by existing-customer expansion and new customers. Management attributed about 70% of the subscription revenue increase to existing customers, including $29.9 million of increased revenue related to Baker Hughes; about 30% came from new customers.
- Baker Hughes-related revenue, including direct subscriptions, services and certain customer revenue under the arrangement, totaled $105.0 million, compared with $55.9 million in FY2021. The company reported that one Customer-Entity represented 31% of FY2022 revenue. Baker Hughes commitments for FY2023–FY2025 were revised to $85 million, $110 million and $125 million, respectively, and future amounts are subject to reductions for specified customer revenue and estimates of variable consideration.
- Other income included a $9.4 million award of attorneys’ fees and costs received in January 2022. The company also recognized $16.0 million of deferred sales commission related to the amended Baker Hughes arrangement, to be amortized over an expected five-year period.
- Investing cash flow was positive $317.0 million, largely reflecting investment maturities and sales, net of purchases; it should not be read as operating cash generation. Financing cash flow was positive $5.7 million and included $15.0 million of stock repurchases, partly offset by option-exercise proceeds.
- The company approved a stock repurchase program of up to $100 million; $15.0 million had been used by year-end, leaving $85.0 million available.
Outlook, risks and contingencies
- No quantified revenue or earnings guidance is provided in the supplied filing. Management expects continued operating losses and negative operating cash flow in the foreseeable future, alongside continued investment in product development, sales, marketing, and international growth. It stated that cash and investments should support working capital and capital expenditures for at least the next 12 months.
- Management said COVID-19 disruption adversely affected the conclusion of new and additional agreements in FY2020–FY2022 and may continue to affect sales cycles and demand.
- Key business risks include customer and revenue concentration, renewals and expansion uncertainty, long and variable sales cycles, reliance on strategic partners, competition, and execution of a shift toward more small and mid-sized customers. The reported customer-count definition was revised during FY2022, making the new counts not comparable with previously reported historical counts.
- Additional risks include privacy, cybersecurity and service interruptions; changing regulations; foreign-exchange exposure (the company does not hedge currently); and the need to sustain liquidity while funding losses. The new Redwood City lease has approximately $103.1 million of undiscounted base rent over its term, subject to lease terms and tenant-improvement allowances.
- A putative securities class action filed in March 2022 alleges misstatements concerning Baker Hughes and other alliances, market potential and product uptake; a related derivative action was filed in May 2022. The company said it did not believe the claims had merit or that an unfavorable outcome was probable, while acknowledging a material impact could be possible if outcomes turn unfavorable.
- The company reported effective disclosure controls and internal control over financial reporting; Deloitte issued unqualified opinions on the financial statements and internal controls. The company ceased to be an emerging growth company as of April 30, 2022, increasing public-company compliance requirements.
Important facts for investors to verify
- How revenue concentration and Baker Hughes’ commitments, resale activity, commissions and variable-consideration estimates affect reported and future revenue.
- Whether RPO converts to revenue as expected, considering timing, customer consumption, renewals and exclusions from the metric.
- Whether customer growth and expansion can outpace substantially higher operating expenses and stock-based compensation while reducing losses and cash burn.
- The revised customer-count methodology and the underlying trend in comparable customers, retention and contract values.
- Developments in the securities and derivative litigation, and any related financial or governance consequences.
- Liquidity needs, investment-portfolio valuation, lease commitments and the remaining repurchase authorization.